h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
CPGHi001-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
CPGHi001-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
CPGHi001-A (RRID:CVCL_A9XF)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
7th September 2020
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Chinese PLA General Hospital (CPGH)
External Databases
Cellosaurus
CVCL_A9XF
Wikidata
Q102113715
General Information
Publications
Wang H et al. Generation of a human induced pluripotent stem cell line (CPGHi001-A) from a hearing loss patient with the TMC1 p.M418K mutation. Stem cell research. 2020 Dec;49:101982.
Zhang Xiaolong et al. Progression of
KCNQ4
related genetic hearing loss: a narrative review. Journal of Bio-X Research. 2021-12-30.
Panda Naresh Kumar et al. Novel Cellular Stress Models with Implications in Understanding and Treating ENT Pathologies. Biomedical Translational Research. 2022-00-00.
Wang R et al. Identification of a novel AIFM1 variant from a Chinese family with auditory neuropathy. Frontiers in genetics. 2022;13:1064823.
Wang H et al. Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9. Stem cell research. 2022 Apr;60:102736.
Nist-Lund C et al. Advancements in inner ear development, regeneration, and repair through otic organoids. Current opinion in genetics & development. 2022 Oct;76:101954.
Durán-Alonso MB et al. Induced Pluripotent Stem Cells, a Stepping Stone to In Vitro Human Models of Hearing Loss. Cells. 2022 Oct 21;11(20).
Luo Yi et al. Genetic correction of induced pluripotent stem cells from a DFNA36 patient results in morphologic and functional recovery of derived hair cell-like cells. Stem Cell Research & Therapy. 2024-01-02.
Zhang Xiaolong et al. Natural History of
KCNQ4
p.G285S
Related Hearing Loss, Construction of
iPSC
and Mouse Model. The Laryngoscope. 2024-05-00.
Yin X et al. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing. Journal of biomedical science. 2024 May 9;31(1):47.
Subclones
CPGHi001-A-1
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.